Davis Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Davis Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.4K	Buy	59 +40	+211%	+$2.3K	﹤0.01%	345
2026 Q1	$1.15K	Buy	19 +6	+46%	+$350	﹤0.01%	322
2025 Q4	$701	Sell	13 -3	-19%	-$144	﹤0.01%	364
2025 Q3	$722	Buy	+16	New	+$747	﹤0.01%	364
2024 Q2	–	Sell	-582	Closed	-$30.8K	–	319
2024 Q1	$30.8K	Sell	582 -552	-49%	-$28.1K	0.03%	164
2023 Q4	$58.2K	Buy	+1,134	New	+$59.5K	0.06%	115
2020 Q2	$355K	Hold	6,038	–	–	0.66%	52
2020 Q1	$337K	Buy	+6,038	New	+$369K	0.72%	51

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davis Capital Management's BMY Position: Q2 2026 in Review

Davis Capital Management increased its Bristol-Myers Squibb (BMY) stake by 211% in Q2 2026, buying an estimated $2.3K and bringing the position to 59 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #345.

Davis Capital Management first reported a position in BMY in Q1 2020 and has held it in 8 quarters since. The position peaked at $355K in Q2 2020. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Davis Capital Management held 59 shares of Bristol-Myers Squibb worth $3.4K as of Q2 2026.
Davis Capital Management bought 40 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.3K.
Bristol-Myers Squibb made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #345 holding.
Davis Capital Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 8 quarters since.
Davis Capital Management's Bristol-Myers Squibb position peaked at $355K in Q2 2020.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.